{"product_id":"cmc-regulatory-compliance-for-biopharmaceuticals-updated-guide","title":"CMC Regulatory Compliance for Biopharmaceuticals - Updated Guide","description":"\u003cp\u003eIn this review of CMC Regulatory Compliance for Biopharmaceuticals the author John Geigert offers a focused resource for regulatory, QA\/QC and manufacturing professionals. The book's single biggest reason to buy is its practical examination of how quality assurance and quality control must evolve across development stages to meet a growing body of guidances; readers seeking a grounded, regulatory-focused perspective will find the update especially useful. This review highlights where the book helps operational teams, what it covers about recent guidances, and who will benefit most from its strategic framing.\u003c\/p\u003e\n\u003ch2\u003eKey Features\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoverage of QA\/QC roles:\u003c\/strong\u003e Explains the strategic importance of QA\/QC involvement in manufacturing control so teams can align quality systems with regulatory expectations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGraded approach guidance:\u003c\/strong\u003e Outlines a graded approach from early clinical trials through market approval to help prioritize activities and controls by development stage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory update summary:\u003c\/strong\u003e Summarizes the impact of more than 50 new FDA, EMA and ICH guidances issued since 2004, giving readers context for current compliance demands.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiosimilars context:\u003c\/strong\u003e Describes the emergence and regulatory development of biosimilars in Europe and the USA to inform strategy and comparability planning.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePractical focus:\u003c\/strong\u003e Emphasizes value generated by QA\/QC in manufacturing control so professionals can justify and design quality interventions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho It's For\u003c\/h2\u003e\n\u003cp\u003eThis book is best for quality assurance and quality control managers, regulatory affairs professionals, and manufacturing leaders working in biopharmaceutical development who need a concise review of contemporary CMC expectations. It is particularly helpful for those building or revising quality strategies to address a rapidly changing guidance landscape.\u003c\/p\u003e\n\u003cp\u003eThose looking for laboratory protocols, step-by-step analytical methods, or highly technical chemical process details should look elsewhere; the book is framed around regulatory strategy and quality oversight rather than bench procedures or synthetic chemistry techniques.\u003c\/p\u003e\n\u003ch2\u003ePros \u0026amp; Cons\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePros\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProvides a clear strategic case for early and graded QA\/QC involvement, useful for organizational planning.\u003c\/li\u003e\n\u003cli\u003eCollects the effects of many recent guidances into one narrative, saving readers time in catching up on regulatory change.\u003c\/li\u003e\n\u003cli\u003ePlaces biosimilars development in regulatory context, aiding comparative planning for product developers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCons\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNot a laboratory manual; readers seeking technical assay instructions will find the scope deliberately managerial and strategic.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eTitle\u003c\/td\u003e\n\u003ctd\u003eCMC Regulatory Compliance for Biopharmaceuticals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuthor\u003c\/td\u003e\n\u003ctd\u003eJohn Geigert\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubject\u003c\/td\u003e\n\u003ctd\u003eQuality assurance, quality control, regulatory strategy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory scope\u003c\/td\u003e\n\u003ctd\u003eFDA, EMA and ICH guidances (50+ since 2004)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAudience\u003c\/td\u003e\n\u003ctd\u003eQA\/QC, regulatory affairs, manufacturing professionals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFocus\u003c\/td\u003e\n\u003ctd\u003eGraded QA\/QC approach from trials to approval\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003eOur Verdict\u003c\/h2\u003e\n\u003cp\u003eJohn Geigert's updated guide is a practical, strategically minded resource for quality and regulatory professionals in biopharmaceuticals. It is good value for teams that must interpret a growing set of guidances and design a graded QA\/QC approach across development stages, though it is not intended as a technical lab reference.\u003c\/p\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this book cover recent regulatory guidances?\u003c\/strong\u003e\u003cbr\u003eYes. The update includes discussion of more than 50 new FDA, EMA and ICH guidances affecting CMC compliance since the first edition.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this useful for biosimilars development?\u003c\/strong\u003e\u003cbr\u003eYes. The book broadens coverage to include the development and regulatory application of biosimilars in Europe and evolving practice in the USA.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill I find laboratory methods in this book?\u003c\/strong\u003e\u003cbr\u003eNo. The focus is on regulatory strategy and QA\/QC involvement rather than bench-level protocols or analytical procedures.\u003c\/p\u003e","brand":"John Geigert","offers":[{"title":"Default Title","offer_id":48246880370907,"sku":"1493943995","price":166.32,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/1043\/1707\/files\/61Pf3tKZC7L._SL1178.jpg?v=1776270915","url":"https:\/\/gearmusthave.com\/products\/cmc-regulatory-compliance-for-biopharmaceuticals-updated-guide","provider":"GearMustHave","version":"1.0","type":"link"}